Obesity in patients with end-stage heart failure

被引：1

作者：

Krol, Bogumila ^{[1
]}

Oprzedkiewicz, Aleksandra ^{[2
]}

Szczurek, Wioletta ^{[2
]}

Szygula-Jurkiewicz, Bozena ^{[3
]}

机构：

[1] Silesian Ctr Heart Dis, Off Transplant Coordinat, Dept Cardiosurg Transplantol Vasc & Endovasc Surg, Zabrze, Poland

[2] Med Univ Silesia, Sch Med, Dept Cardiol 3, Div Dent Zabrze,Student Sci Soc, Katowice, Poland

[3] Med Univ Silesia, Sch Med, Dept Cardiol 3, Div Dent Zabrze, Katowice, Poland

来源：

KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA | 2018年 / 15卷 / 03期

关键词：

obesity; end-stage heart failure;

D O I：

10.5114/kitp.2018.78442

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Obesity poses an increasing problem in patients with end-stage heart failure (HF). The most commonly used indicator of obesity is body mass index. The value of this parameter is widely taken into consideration when selecting the best way of treatment for patients with advanced HF. The aim of this paper is to outline the recent knowledge about obesity in the abovementioned group of patients.

引用

页码：176 / 179

页数：4

共 50 条

[31] Artificial Muscle for End-Stage Heart Failure
Tozzi, Piergiorgio
Michalis, Alexandre
Hayoz, Daniel
Locca, Didier
von Segesser, Ludwig K.
ASAIO JOURNAL, 2012, 58 (02) : 103 - 108
[32] Surgical therapy of end-stage heart failure
Christiansen, S
Brose, S
Autschbach, R
HERZ, 2003, 28 (05) : 380 - 392
[33] End-Stage Heart Failure in Cardiac Sarcoidosis
Velikanova, Diana
Poyhonen, Pauli
Lehtonen, Jukka
Simonen, Piia
Uusitalo, Valtteri
Vihinen, Tapani
Kaikkonen, Kari
Haataja, Petri
Kerola, Tuomas
Rissanen, Tuomas T.
Vepsalainen, Ville
Alatalo, Aleksi
Pietila-Effati, Paivi
Kupari, Markku
CIRCULATION, 2024, 149 (11) : 885 - 887
[34] Medical treatment of end-stage heart failure
Binetti, G
Senni, M
Colombo, F
Tasca, G
Mamprin, F
Caporale, R
Ferrazzi, P
Gamba, A
Glauber, M
Troise, G
Fiocchi, R
CARDIOVASCULAR DRUGS AND THERAPY, 1996, 10 : 617 - 622
[35] Therapeutic Options in End-Stage Heart Failure
Ensminger, S.
Puehler, T.
Schulz, U.
Fuchs, U.
Schonbrodt, M.
Morshuis, M.
Borgermann, J.
Hakim-Meiboudi, K.
Gummert, J.
AKTUELLE KARDIOLOGIE, 2014, 3 (03) : 179 - 187
[36] Growth hormone in end-stage heart failure
Wilmshurst, P
LANCET, 1997, 349 (9068): : 1842 - 1843
[37] Surgical management of end-stage heart failure
Sharkey, A.
Warriner, D.
Braidley, P.
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (11) : 633 - 639
[38] Molecular Signatures of End-Stage Heart Failure
Lin, David
Hollander, Zsuzsanna
Meredith, Anna
Stadnick, Ellamae
Sasaki, Mayu
Freue, Gabriela Cohen
Qasimi, Pooran
Mui, Alice
Ng, Raymond T.
Balshaw, Robert
Wilson-McManus, Janet E.
Wishart, David
Hau, David
Keown, Paul A.
McMaster, Robert
McManus, Bruce M.
JOURNAL OF CARDIAC FAILURE, 2011, 17 (10) : 867 - 874
[39] Advanced Therapies For End-Stage Heart Failure
Katz, Jason N.
Waters, Sarah B.
Hollis, Ian B.
Chang, Patricia P.
CURRENT CARDIOLOGY REVIEWS, 2015, 11 (01) : 63 - 72
[40] End-stage heart failure: which options?
Deng, MC
Ascheim, DD
Edwards, NM
Naka, Y
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2002, 4 (0D) : D122 - D130

← 1 2 3 4 5 →